The classic concept of massive hemoptysis has been replaced by the newer one of life-threatening hemoptysis (LTH), which means any bleeding from the lower respiratory tract that may cause the death of the patient. Although asphyxia is the usual mechanism of death, hypovolemic shock also plays a role in certain cases. The amount of expectorated blood does not always correlate with the actual volume of bleeding. The underlying state of health, especially basal respiratory function, plays a crucial role when the real consequences of bleeding are considered. The following factors have to be evaluated when a temporary or definitive treatment is chosen: setting of the hemoptysis, presumptive etiology, degree of clinical instability, equipment resources, and personal expertise in different techniques. The most important role of bronchoscopy is its rapid availability when hemoptysis is severe and the patient is not sufficiently stable to be immediately taken to the angiography department. In that situation, orotracheal intubation and bronchoscopy may be lifesaving. Rigid bronchoscopy, in skilled hands, has proven to be superior to flexible bronchoscopy in massive hemoptysis. Fiberoptic bronchoscopy (FOB) is also helpful as an extreme emergency measure to properly place an orotracheal tube contralateral to the bleeding side. Endoscopic local measures may sometimes help to transitorily stop bleeding. If the cause of hemoptysis is itself susceptible to primary surgical treatment and the condition of the patient is sufficiently good in terms of pulmonary reserve, life expectancy, and hemodynamic stability, then surgery is indicated. If the condition of the patient is not good enough, a temporary method to stop hemorrhage and stabilize the patient is then warranted. Although bronchoscopy and bronchial artery embolization (BAE) should be ideally complementary, recent data suggest that BAE may be a more effective temporary measure to stop bleeding.
H emoptysis refers to the expectoration of blood that originates from the lower respiratory tract. From a general point of view, it is a common symptom that may result from a wide range of causes. Occasionally, blood from the upper gastrointestinal tract or upper respiratory tract may closely mimic hemoptysis. 1, 2 The prognosis is good in most cases of mild hemoptysis, even if the underlying cause remains unidentified. In the case of LTH, a consistent negative predictive factor is massive bleeding itself and the presence of some specific causes, such as lung malignancy or bleeding diathesis. 3 In spite of the difficulties inherent in a case of LTH, clinicians have to attempt an etiologic diagnosis because some of the etiologies, as we will see later, require a therapy that is not included in other general therapeutic recommendations.
Three factors are probably more decisive than the volume of expectorated blood: the basal state of health of the patient, especially cardiovascular status and pulmonary reserve; the speed of bleeding; and the amount of blood that may be retained within the lungs without being brought up. 4 This last and sometimes-neglected phenomenon is a frequent problem in hemoptysis caused by diffuse alveolar hemorrhage (DAH), whatever the etiology, [5] [6] [7] and also may be sometimes expected in elderly people with low respiratory muscle strength and chronic difficulties in expectorating. Bronchoalveolar lavage revealing an increasingly bloody lavage fluid return is the key to diagnosing alveolar hemorrhage. A list of causes of DAH is shown in Table 1 .
The term massive hemoptysis is variably applied in the literature. The volume of expectorated blood has ranged from 200 mL to as much as 1,000 mL during 24 to 48 hours in different series. 8, 9 When a patient is bleeding actively on clinical presentation, there is a clear risk of death through asphyxia or hemodynamic collapse. Then, a more aggressive therapeutic approach is mandatory. In this situation, we believe it should be called massive hemoptysis, whatever the amount of expectorated blood; clinical anamnesis is not feasible because patient, relatives, and even health providers usually panic. Sometimes, clinical information may be obtained from patient records, but the first rule is to prevent the patient from dying from respiratory failure or hypovolemic shock. Here, the frontier between LTH and massive hemoptysis is subtle and depends on clinical judgment. A difficulty is that LTH and even massive hemoptysis often are not heralded by any progressive increase in the volume of hemoptysis. Consequently, there must be awareness of the large list of potential causes of LTH. Moreover, all medical centers should have a customized protocol to effectively treat this frightening condition, according to local expertise and technical equipment availability.
THORACIC COMPUTED TOMOGRAPHY (CT)
Thoracic scan is a reputable complementary test in the search for a cause of hemoptysis, especially when a chest radiograph is not sensitive enough to identify any abnormality. However, its role in LTH and massive bleeding is not so clear. 4, 8, 9 The top priority is to avoid asphyxia and to ensure proper ventilation and hemodynamic stability, goals not within the scope of benefits derived from CT. Some CT findings may be extremely helpful in clinical differential diagnosis. CT can detect occult lung abnormalities unobserved in the radiograph. CT is frequently invaluable in the early detection of cavitation and the "halo-sign" within an infiltrate, when a chest radiograph fails to show this information. These findings are helpful in increasing the index of suspicion of certain aggressive, necrotic lung infections with a high risk of unexpected massive bleeding, such as aspergillosis or mucormycosis. 10 -13 An early diagnosis of these causes could favor a more effective surgical therapeutic approach, as discussed later. High-resolution CT is most useful in the diagnosis of bronchiectasis, to the point that bronchography has been abandoned. Helical CT has provided significant insight into the diagnosis of pulmonary embolism and aortic dissection, 2 specific causes of potential LTH that require distinctive therapeutic approaches. The diagnostic yield is not so high in other etiologies, such as pulmonary arteriovenous vascular malformations. In this case, diagnosis by contrast-enhanced magnetic resonance angiography also has been recently reported, but the effectiveness of this method may be inhibited by severe active bleeding. Pulmonary arteriography seems superior in this particular setting because it permits a combined diagnostic and therapeutic procedure. CT scanning has some pitfalls, the most common being that accumulated blood in dependent areas or clots in the bronchial lumen may be misleading and suggest tumor. Moreover, except in those cases stated above, in which CT-based diagnosis may indicate the need of urgent surgery, scanning does not usually lead to any immediately effective treatment. Finally, in cases of massive hemoptysis, removal of an unstable patient from the intensive care unit (ICU) is injudicious unless a therapeutic procedure is planned.
ETIOLOGY
The likely decreasing frequency of massive hemoptysis, at least in developed countries, is reflected in the scarcity of large series in the last decade. 14, 15 In general, it seems clear that the etiology of LTH and massive hemoptysis in advanced countries has shifted from infection-derived causes to other etiologies. Chronic inflammatory bronchial and lung diseases are probably the leading causes of LTH in the United States and part of Europe. The incidence of specific diagnoses varies depending on geographic areas with a higher prevalence of causes related to active infection, such as tuberculosis, hydatidic cyst, or paragonimiasis in Third World countries. Improvement in diagnostic methodology and the trend to more invasive diagnostic procedures have undoubtedly contributed to the decrease in the percentage of cases of LTH of unknown cause and the increase of other etiologies that previously have been underestimated. For example, the widespread availability of bronchial arteriography has taught us that some, until now, presumptive causes of hemoptysis, such as chronic bronchitis, may in fact result from impressive, occult vascular lesions that perfectly explain even a life-threatening bleeding. 16 In tertiary centers, the impact of underlying anticoagulant therapy seems to have prognostic implications. In a recent retrospective series reported by Alobeidy et al, 17 as many as 26% of patients who presented hemoptysis were receiving anticoagulation therapy, and mortality among them was 30%. The most frequently identified causes in this study, which was not exclusively focused on LTH, were pneumonia and inflammatory abnormalities.
An exhaustive MEDLINE search on less-known causes of LTH has enabled us to elaborate a list of uncommon potential etiologies ( Table 2 ). Some of them have been neglected, basically because of their rarity. 18 -25 However, it is advisable to keep them in mind because many require a specific diagnostic and therapeutic approach. In some cases, a delay in diagnosis may worsen the outcome. The progressive increase in incidence of iatrogenic causes in LTH has encouraged us to elaborate in Table 3 a summary of medical and surgical procedures associated with LTH. A list of those drugs that have been reported to be effective in medical treatment of LTH is shown in Table 4 .
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FOB
FOB is a valuable diagnostic technique in mild to moderate hemoptysis, but its principal role in LTH is to identify the site of bleeding and to offer immediate temporary measures to stop bleeding in severe cases. 34 It is well known that when FOB is performed during active bleeding, there is 
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Approach to Life-Threatening Hemoptysis a decreased diagnostic yield but an increased potential to identify the bleeding site. Once considered the first step when LTH was encountered, the role of FOB has been progressively supplanted by the better results obtained with BAE, provided that this technique is available and is performed by skilled angiographers. 35 In fact, both techniques, FOB and BAE, should be complementary and rapidly sequential whenever possible. We think that the most important role of FOB is its rapid availability when hemoptysis is severe and the patient is not sufficiently stable to be immediately taken to the angiography department. If the patient needs to be stabilized by intubation, it often takes little time for bedside FOB in the ICU. This may give a suggested location for bleeding that can help angiographers know where to start. In that situation, large channel FOB performed with intubation may be lifesaving if endoscopic local measures to stop bleeding are properly applied. In LTH, it is strongly recommended that a rigid bronchoscope be at hand in case the flexible bronchoscope is insufficient to control the hemorrhage. If the bleeding is massive, that is, the patient is asphyxiating or collapsing in spite of intubation and frequent suctioning, initial rigid bronchoscopy is mandatory if available. 34, 36 A variety of local methods to stop endobronchial moderate bleeding has been described. In severe hemorrhage, blocking of the lumen from the region of bleeding is an effective temporary method of stopping the hemoptysis. § Instillation of amphotericin B, sodium iodide, potassium iodide, paste of glycerin, and amphotericin B, epsilon-amino-caproic acid.
34
Recent reports suggest that triazoles offer a safer and effective alternative to amphotericin B.
Some types of tamponade balloons are commercially available, the Fogarty catheter being the most popular. Familiarity with a specific type is crucial to ensure appropriate placement and good results. Placement of double-lumen tubes again requires an experienced operator. They are designed to permit adequate suctioning of blood, but the capacity for suction is inferior to the large channel of other tubes or rigid bronchoscopy. An excellent in-depth review of the advantages and pitfalls of double-lumen tubes has been recently published. 37 Recent surveys among pulmonologists show that the majority do not rely on endoscopic measures. A report by Haponik et al 38 showed that as many as 77% of practitioners attending the 1998 American College of Chest Physicians annual scientific assembly had experience of endobronchial measures to control bleeding; however, only 14% of them found these really effective. This lack of confidence in endobronchial techniques runs parallel to a progressive confidence in the efficacy of interventional angiography. In the same survey, 50% of clinicians were in favor of angiographic procedures, a substantial increase compared with the 23% who favored this approach 10 years before. These data coincide with a recent study supporting the performance of rapid arteriography with embolization, if feasible, instead of an initial endoscopic procedure. 35 The usual techniques consist of the instillation of cold saline or dilute epinephrine through the bronchoscope. A potentially more appealing approach is the intralesional injection of epinephrine solution through a transbronchial cytology needle, although it has only been reported in a recent case of a bleeding endobronchial tumor. 39 There has been a report of a massive hemoptysis caused by advanced lung cancer being successfully stemmed by injecting cyanoacrylate glue as a filling material in conjunction with a dynamic stent. 40 To the best of our knowledge, preliminary studies suggesting that some benefit could be obtained from endobronchial infusion therapy with thrombin have not been validated by later studies until now.
FOB is helpful as an emergency measure to properly place an orotracheal tube contralateral to the bleeding side and protect ventilation on that side. The success of this method depends on the previous identification of the bleeding side, either by endoscopic visualization or by means of presumptive location according to clinical and radiologic features.
RIGID BRONCHOSCOPY
Rigid bronchoscopy is believed to be superior to flexible bronchoscopy in massive hemoptysis, a situation in which the speed and volume of bleeding may often overtake the suctioning capacity of the relatively narrow channel of all flexible bronchoscopes. 34, 36 The advantages of effectively cleaning the airways and ensuring permeability must be balanced against reality: Many pulmonologists are not sufficiently trained in the art of rigid bronchoscopy; consequently, this technique has become progressively underused. A recent survey of the American College of Chest Physicians has shown that as many as 70% of pulmonologists are not in the habit of performing rigid bronchoscopy. 38 In many instances, this unfamiliarity precludes its indication for massive hemoptysis because the frightening situation produced by massive bleeding makes the method inadvisable in unskilled hands. Rigid bronchoscopy also may require movement to the operating room, with potential hazards of transport. Cryotherapy, which requires rigid bronchoscopy, has been found to be useful in the treatment of bleeding endobronchial mucormycosis and tracheobronchial amyloidosis. Laser resection also may be useful to remove exophytic, bleeding, proximal airway lesions.
BAE
Bronchial and other collateral systemic arteries are now considered the source of bleeding in the majority of cases of LTH. 41 Pulmonary arteries are probably responsible for less than 10% of cases. Pulmonary arteriography instead of initial bronchial angiography now usually is restricted to clinical suspicion of pulmonary aneurysms, arteriovenous malformations, and sometimes pulmonary embolism. Actual visualization of bleeding through extravasation of contrast is uncommon. However, with bronchiectasis there is enough evidence supporting confident inference of the bleeding site from the finding of hypervascularized, tortuous areas on angiography. Anatomic variability is a characteristic feature of the bronchial circulation, which has to be taken into account because it may hamper the effectiveness of BAE.
The contribution of nonbronchial systemic collateral vessels seems to be particularly relevant when pleural disease is observed on the chest radiograph. The most significant factor affecting long-term results is whether the inflammation caused by the underlying disease can be medically controlled. The degree of severity of the angiographic findings does not seem to be a predictive factor of long-term results. A variety of nonbronchial systemic arteries, especially intercostal arteries, may be involved in hemoptysis. Branches from Table 5 .
SURGERY
If the primary process that causes bleeding intrinsically requires a surgical therapeutic approach and the condition of the patient is good enough in terms of pulmonary reserve, life 
Roig et al
Clinical Pulmonary Medicine • Volume 10, Number 6, Nov-Dec 2003 expectancy, and hemodynamic stability, then surgery is indicated urgently. It must be kept in mind that, at least in older series, urgent surgical procedures, most likely in unstable patients, were associated with a higher morbidity that elective surgery. In consequence, if the condition of the patient is not good enough, a temporary method to stop hemorrhage and stabilize the patient is then warranted. 9, 15 Usually, angiography with embolization is the preferred method, although its success in certain etiologies, such as mycetoma or malignant tumors, has been relatively low compared with surgery, in some series. [42] [43] [44] [45] [46] [47] [48] An innovative surgical approach to massive hemoptysis, as an alternative to conventional surgery, has been recently reported. It is called physiological lung exclusion and has been found to be extremely helpful in cases of LTH that occur in high-risk surgical patients in whom bronchial angiography embolization has failed. 49, 50 By means of extrapleural thoracotomy, surgical interruption of the bronchus and pulmonary artery of the involved lobe or lung is performed without ligating the pulmonary veins. The method, sometimes performed bilaterally, was previously found efficacious in cystic fibrosis-related LTH. 51 This procedure has now been expanded into other similar clinical situations. Postoperative recovery is accelerated if muscle-sparing thoracotomy and postoperative epidural analgesy are used.
THERAPEUTIC APPROACH TO LTH
Although a worldwide consensus has not been achieved, some general recommendations are usually accepted in most review articles. 4, 9, 14, 15 Application of the conclusions suggested by classic studies is hampered by the following: Those studies usually considered a selection of patients who could benefit from surgery. For patients with a poor pulmonary reserve, there was a dramatic lack of the nonsurgical therapeutic options commonly available today. The progressive increase of invasive diagnostic and therapeutic procedures goes hand in hand with an increased risk of iatrogenic LTH, a condition almost negligible in the old series. Our point of view is that clinicians should avoid any dogmatic approach to dynamically adapt to the situation of each patient and to the real diagnostic and therapeutic options of any specific setting. Table 6 shows our proposal for an algorithmic approach to LTH. General measures are listed in Table 7 . It must be emphasized that some causes are not included in this general approach, in particular DAH; mitral stenosis; and aneurysms associated with some vasculitides, such as Behcet disease, Hughes-Stovin syndrome, or Takayasus arteritis. These causes can dramatically respond to corticosteroids and immunosuppressive treatment. LTH associated with aortobronchial fistulas may be successfully treated with endoluminal stent graft repair. 52, 53 In summary; when there is an identified entity causing the bleeding and underlying condition is sufficiently good, and the treatment of choice of the primary process is usually surgical resection (localized bronchiectasis, tumor, mycetoma, etc.), surgery is indicated once clinical stability has been obtained. If the patient is not fit for surgery because of hemodynamic instability or poor pulmonary reserve, angiography with embolization is usually the best therapeutic option because urgent surgery in unstable patients is associated with a high risk of morbidity and mortality. However, in certain circumstances, BAE may be not successful. Failure to stop bleeding may be due to technical drawbacks or to the relatively low success sometimes observed in determined specific causes, such as necrotic tumors or cavitary infections (mycetoma, cavitary invasive fungal infection, abscess). 10 -13,42-48 On the other hand, in the case of patients for whom medical ‡ A differential diagnosis of the cause of LTH should always be attempted. Pulmonary and thoracic surgery specialists consultation is warranted.
§ Consider obtaining a bleeding time if suspected qualitative platelet dysfunction, either drug-related or underlying disease-related, such as happens in uremia.
Such as antineutrophil cytoplasm antibodies (ANCA), anti-GBM antibodies, antinuclear antibodies, microbiologic testing.
¶ In stable patients not requiring intubation, some diagnostic procedures may be indicated according to clinical suspicion, such as echocardiogram, perfusion and ventilation lung scan, and thoracic CT. treatment is usually effective, temporary measures to stop bleeding are recommended as the first step.
